A unique subset of y6 T cells, termed dendritic epidermal T cells (DETC) , resides in symbiosis with keratinocytes in mouse epidermis. W e have shown previously that interleukin 7 (IL-7) which is produced by keratinocytes, promotes groW"th and prevents ~poptosis in I?ETC. To exten~ th!s o bservation, we examll1ed 12 cytokll1es, each of which IS expressed by eJ:>i.dermal cells at mRNA and/or protein levels, for their capaCities to modulate th e growth ofDETC. Cytokines examined included IL-1a, IL-2, IL-3 , IL-4, IL-6, IL-7, IL-8, IL-10, tumor necrosis factor-a (TNFa), interferon-y (IFNy), granulocyte/macrophage-colony stimulating factor (GM-CSF), and macrophage inflammatory protein-1a (MIP-la) . When tested individually, IL-2 and IL-7 promoted maximal growth of the long-term cultured DETC line 7-17. When tested in combinations, synergistic growthpromoting effects were seen with IL-2 and IL-4 or IL~7 , and w ith IL-7 and IL-4 or TNFa. Dose-response expenments T he concept of immune regulation by cytokines produced in the epidermis can be dated to the discovery that keratinocytes elaborate interleukin-1 (IL-1) [1] [2] [3] . Keratinocytes, which possess overwhelming numerical superiority in mammalian skin, are now know n to produce a spectrum of cytokines, including IL-1a, IL-l{J, IL-3 , IL-6, IL-8, granulocyte/macrophage colony-stimulating fa~ tor (GM-CSF) , and tumor necrosis factor a (TNFa) (reViewed 111 [4 -6]). Recently, IL-7 and IL-I0 ~ave b~en added t.o this list [7, 8] .
T he concept of immune regulation by cytokines produced in the epidermis can be dated to the discovery that keratinocytes elaborate interleukin-1 (IL-1) [1] [2] [3] . Keratinocytes, which possess overwhelming numerical superiority in mammalian skin, are now know n to produce a spectrum of cytokines, including IL-1a, IL-l{J, IL-3 , IL-6, IL-8, granulocyte/macrophage colony-stimulating fa~ tor (GM-CSF) , and tumor necrosis factor a (TNFa) (reViewed 111 [4 -6] ). Recently, IL-7 and IL-I0 ~ave b~en added t.o this list [7, 8] .
In mice, keratlnocytes live 111 symbIOSIS With two reSident leukocyte populations: Langerhans cell s and dendritic epidermaJ T cells (DETCs) . W e and others have shown that Lan?erhans cell.s, whi~h are antigen-presentm g cells of dendritiC cell llI1eage (reViewed 111 [9] ), are capable of expressing mRNA for and/or secreting at least three cytokines, IL-1{J, IL-6, and macrophage 1I1fIammatory protein-lll'(MIP-1a) [10] [11] [12] . DETCs, which are CD3+, CD4-, CD8-, yt5 T-cell receptor (Tc ny, arc one member of a family of ~6 T cells that reside preferentiall y in epithelial tissues (reViewed 111 [13, 14] ). DETCs, also a source of cytokines, arc known to secrete Manuscript received March 9, 1993 ; accepted for publication June 3, 1993 .
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Abbreviations: DETC, dendritic epidermal T cell; DEX, dexamethaso ne; yIFN, interferon-y; MIP-la, mac rophage inflammatory protein-la. demonstrated that TNFa, which is produced by keratinocytes, enhances IL-7 -induced DETC proliferation, but inhibits IL-2 -indu ced proliferation. The mouse keratinocytederived cell line Pam 212 was used to test these cytokines for their capacities to regulate keratinocyte growth. Only yIFN , which is produced by DETC, inhibited proliferation in a dose-dependent fashion. These results illustrate three reciprocal p athways by which epiderma l cytokines regulate the growth of epidermal cells: 1) a paracrine mechanism by which keratinocyte-derived cytokines (e.g., IL-7 and TNFa) promote the growth of DETC, 2) an autocrine mechanism by which DETC-derived cytok ines (e.g., IL-2 and IL-4) support their own growth, and 3) a reciprocal path way in which a cytokine produced by resident epidermal leukocytes (e. g., yIFN) modulates th e growth of keratinocytes. Key words:
epiderm al y6 T cell/keratinocyte/ growth/ cytokine. ] Invest Dermatoll 01 : 543 -548, 1993 IL-2, IL-3 , IL-4, and interferon-Y(IFNY) [15 -17] , and recently we have observed that th ey also express mRNA for IL-la, IL-6, IL-7, TNFa, TNF{J, GM-CSF, and MIP-la. * An important iss ue, then, is th e ro le these cytokines play in regulating their own epidermal microenvironment. In fact, several keratinocyte-derived cytokines, i. e., IL-la, GM-CSF, and TNFa, have been shown to promote the growth and/or th e maturation of Langerhans cells [18 -21] . Likewise, we have shown that keratinocyte-derived IL-7 serves as a growth factor for DETCs. t Moreover, IL-7 prevents apoptotic cell death that would ordinarily be induced in DETCs when exposed to exogenous corticosteroids.:j: Thus, keratinocytes support the growth and survival of these two resident epidermal leukocytes through the elaboration of relevant cytokines and growth factors. In the present study, this line of investigation was extended by examining 12 cytok ines, all of which are likely to be present under normal or pathologic circumstances in mouse epi-.
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eration by ep iderm al cytok ines. 7-17
DETCs were stimul ated with Con A IL-+ (12.5ng/ml) and tes ted 2 d later for pro liferative responsiveness to selected cytokin es, at three different concentrations: hi gh
(shown in parfllthcses), med ium (five times di lution) , and low (25 times dilu-
ti on). Data shown are the means ± SEM (n = 3) for 3 H-thymidine incor-
poratio n harvested on day 2 (lift) or day GJ.4 -CSF (50ng/ ml)
(right).
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Yale University). 7-17 DETCs have been used extensivel y by several investi ga tors, and their other characteristics are described elsew here [1 6,24,25] . BALB/c mouse keratinocyte-derived Pam 212 cell s [26] were maintained as described previously [27] . Briefly , ce ll s were cultured in Dulbecco's mi nimum esse ntial medium (DMEM) supplemented with the same additives used to suppl ement RPMI1 640 (co mplete DMEM) .
Cytokines Mouse r1L-1 a, r1L-3, rIL-4, rIL-8, rTNFa, rGM-CSF, and rINFy, and human rIL-8 were purchased from Ge nzy me (Cambrid ge, MA); mouse rIL-6 , rlL-7, and rMIP-1 a, and human rIL-2 were from R&D Systcms; and mouse rIL-l 0 we re from Bachem Bioscience, (Philadelphia, PAl.
Proliferation Assays Cell proliferation was determined as described previously [15, 23, 27] . Briefly, 7-17 DETCs were pre-acti vated with Con A (1 Jig/ml) for 18 h, washed extensivel y, and th en cultured for 1 -3 d in th e abse nce of added IL-2. These cell s were th en harvested with EDTA, plated (3 X 10 4 cell s/well) in 96 rou nd-bottom well -plates (Corning, Corning, NY), and cultured for up to 5 d in the presence of each cy tokine or cy tokine co mbinati on. Cells were pulsed with 1 JiCi/well of 3H-thymidine (New England Nuclear, Boston, MA) durin g the last 16 h, and harvested using an automated cell harvester (PHD , Cambrid ge, MA). Pam 212 keratinocytes iso lated from semi-co nfluent culturcs were plated in 96 fl at-bottom wellplates, cultured, and pulsed as above. T hese adherent ce ll s required a brief treatment with trypsin prior to harvesting, as described prev iously [27] . All the data were analyzed for statistica l signifi ca nce by t test for independ ent samples usin g Kwikstat 3.3 (TexaSoft).
Dexamethasone Treatment ofDETCs DETC apoptosis was induced with dexa meth asone (DEX) as described prev iously.:!: Briefly, 7-17 DETCs (1 X 105 cells/well) in a resting state (activated with Con A 9-14 d previously) were cultured in complete RPM! in 24-well plates, in the presence or abse nce of DE X (1 X 10-7 M) . After 20 h, ce ll s were harvested w ith EDTA, and cell viability was assessed by trypan blue excl usion; at least 400 cell s were counted per sa mpl e.
RESULTS
IL-2 and IL-7 are Major Growth Factors for DETCs As described in th e Irltroduction, eac h of th e epidermal cell subpopulations (i. e., keratinocytes, Lan ge rh ans cells, and DETCs) elaborates a distinct pro fil e o f cytokines. Res ults from o ur reverse-transc riptionpolymerase ch ain reacti o n ana lyses are summarized in Table I , which lists cytokine mRNAs expressed by fres hl y isolated epiderm al cells, Pam 212 keratinocytes, FA C S-purified DETCs, shortand lon g-term DETC lines, and FACS-purified Langerhans cells. The term "epidermal cytokines" will be used to identify all of th ese cytokines as a group (IL-la, IL-1 /J, IL-2, IL-3 , IL-4, IL-6, IL-7 , IL-8, IL-I0, IFN y, TN Fa, G M -CSF, ;Uld MIP-la) .
In the first set of experime nts, eac h epiderm al cytokine was tested individually for its capacity to m odul ate DETC proliferatio n . in Fig 1. To begin, 7-17 DETCs showed minimal 3H-thymidine incorporation on days 2 and 5, in the absence of added growth factors (Fig 1) . This baseline proliferation was clearly upregulated by added IL-2, with significant activiry detected even at t!le lowest concentration (0.4 ng/ml) and l!1creasll1g progressively, l!1 a dosedependent fas hion. IL-7 (1-25 ng/m l) also exhibited marked growth-promoting activiry. Importantly, IL-2 and IL-7 promoted DETC growth with different kinetics. IL-2 -induced proliferation occurred rapidly, with substantial 3H-thymidine incorporation on day 2 and less by day 5. By contrast, IL-7 responses were modest on day 2 but remained at that level even on day 5 (Fig 1) . Both IL-4 and TNFa showed modest, but statistically significant (p < 0.01), activities on day 2: 900 ± 50 cpm (baseline), 2400 ± 200 cpm (12.5 ng/m 1 IL-4~, and 2800 ± 40 cpm ~2~ ng/ml TN~a) . All other cytokines failed to promote or to l!11ublt DETC proliferatIOn under the conditions employed for these experiments. 
60
TNFa Augments IL-7 -Induced DETC Proliferation In the next set of experiments, epidermal cytokines were tested in several combinations. In two independent experiments, both IL-4 and IL-7 consistently augmented IL-2 -induced proliferation of DETCs on day 5 (Fig 2A) . These effects were synergistic ratber than additive (p < 0.05); the magnitudes of proliferation were 510 ± 130 cpm (IL-2), 370 ± 60 cpm (IL-4), 21,000 ± 500 cpm (IL-7) for individual cytokines, and 5,900 ± 1,400 cpm (IL-2 plus IL-4), and 35,000 ± 1,300 cpm (IL-2 plus IL-7) in combinations.
When tested in combination with IL-7 , three cytokines (IL-2, IL-4, and TNFa) also showed a synergistic augmentation (p < 0.01) of proliferative responses on both day 2 and day 5 ( Fig 2B) . For example, the magnitudes of proliferation on day 5 were 20,000 ± 1,600 cpm (IL-7) , 460 ± 50 cpm (IL-2), 370 ± 60 cpm (IL-4), 240 ± 40 cpm (TN Fa) for the individual cytokines, and 32,000 ± 2,000 cpm (IL-7 plus IL-2) , 39,000 ± 120 cpm (IL-7 plus IL-4), and 58,000 ± 2,000 (IL-7 plus TNFa) in combinations. These resu lts illustrate both autocrine and paracrine mechanisms by which DETC proliferation is promoted by DETC-derived cytokines (IL-2 and IL-4) and by keratinocyte-derived cytokines (IL-7 and TNFa), respectively. To study the regulatory effect of TNFa more closely, its dose response was examined in combination with IL-2 or IL-7. Surprisingly, TNFa was found to inhibit IL-2-induced DETC proliferation ( Fig 3A) . The IL-2-induced response on day 5 (8,400 ± 1,200 cpm) was inhibited 60% with TNFa, with the effective TNFa concentration in the range between 1.6 and 8 ng/ml. By marked contrast, TNFa augmented IL-7 -induced DETC proliferation (Fig 3B) , an effect that was most prominent on day 2. The IL-7 response (6,600 ± 1,200 cpm) was amplified up to threefold by added TNFa, with this activity occurring at concentrations between 8 and 200 ng/ml. Importantly, proliferative responses to TNFa alone were negligible « 1 000 cpm at each data point). Thus, we conclude that TNFO' augments IL-7 -induced DETC proliferation but inhibits IL-2-induced proliferation.
IL-2, IL-4, and IL-7 Prevent Dexamethasone-Induced DETC Death W e have observed previously that 7-17 DETCs undergo apoptosis in response to ill lIitro treatment with DEX.:j: Cellular changes have included 1) reduced cell viability (trypan blue exclusion),2) DNA fragmentation (DNA laddering ill electrophoresis), 3) a requirement for macromolecule biosynthesis (inhibition by cycloheximide or actinomycin D), and 4) chromatin condensation and loss of microvilli (electron microscopy), all of which typify cells that are undergoing apoptosis (reviewed in [28] ). When IL-7 was added simultaneously with the DEX, apoptosis did not occur.:j: It was, therefore, of particular interest to determine whether DETC apoptosis can be induced or prevented by other epidermal cytokines. First, none of the cytokines induced significant cell death in [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] DETCs in the absence of DEX in any of the three independent experiments (Fig 4, left) . When the same cytokines were tested for
,..... their ability to prevent DEX-induced cell death, three cytokines, IL-2, IL-4, and IL-7, consistently showed significant activities (p < 0.05); cell viabilities were 98% (no DEX), 47% (DEX alone), 98% (DEX plus IL-2), 91 % (DEX plus IL-4) , and 98% (DEX plus IL-7) (Fig 4, right panel) . Relatively modest effects were also observed, but only occasionally, with several other cytokines (i.e., IL-10, TNFa, GM-CSF, and MIP-1a).
yIFN Inhibits the Growth of Pam 212 Keratinocytes Having confirmed the biologic activities of epidermal cytokines on DETC proliferation and apoptosis, additional experiments were conducted to determine whether these same cytokines would modulate the function of other epidermal cells. In the absence of stable lines of Langerhans cells, and recognizing the comprehensive studies of Steinman and his colleagues [19] [20] [21] 29] , we chose to limit this examination to the effects of these epidermal cytokines on keratinocyte growth . Pam 212 keratinocytes were tested for their proliferative responses to added cytokines with two protocols: 1) relatively large numbers of cells, with harvesting on day 2 (Fig SA), and 2) fewer cells, with harvesting on day 5 (Fig 5B) . In both protocols, 3H-thymidine incorporation was measured with cells in the exponential growth phase, as indicated with arrows in the left panel of Fig 5. Pam 212 cell growth was clearly inhibited by added IFNI', under both protocols (p < 0.05 at 20 ng/ml, and p < 0.01 at 100 ng/ml IFNy). Maximal activity (40-60% inhibition) was achieved at a IFNI' concentration of 1 00 ng/ml. All other cytokines failed to promote or to inhibit the growth of this keratinocyte line in two independent experiments.
DISCUSSION
The reported experiments tested 12 different epidermal cytokine for their potential to modulate the growth ofDETCs and keratinocytes. The most striking observations were that IL-7 and TNFa, both of which are produced by keratinocytes [7, 30] , promote the growth of DETCs, in a synergistic fashion . IL-7, which was first I characterized as a bone marrow stroma cell-derived pro-and pre -B-cell growth factor [31, 32] ' has also been demonstrated to serve as 1 a growth factor for early lymphoid cells of both B-and T-cell lineages (reviewed in [33] ). In addition to mature T cells, IL-7 also promotes the proliferation of thymocytes [34 -36] and in our earlier report, we observed that IL-7 also promotes the growth ofDETC. t
Recently, it has become evident that TNFa has the capacity to promote the growth of early thymocytes, especially when com- bined with other cytokines (e.g. , IL-2 and IL-7) [37 -39). Thus, our results suggest that DETCs, which are also derived from thymic ~ precursors and express the identical TCR (i.e., Vy3/VJ1) to that found on day 16 thymocytes [40, 41] , resemble early thymo~ytes . in their g rowth-factor req uirements as well. Thus, these findm gs illustrate paracrine mec hanisms by which cytokines (e.g., IL-7 and TNFa) produced by neighboring keratinocytes promote the growth of epidermal resident yo T cells. IL-2 also induced marked proliferation of 7-17 DETCs, corroborating our previous observations with DETCs freshly procured from skin (23) . On the other hand, IL-4 sy nerglzed With IL-2 or IL-7 to enhance DETC proliferation substantially. We and others have s hown that DETCs are capable of producing these two cytoh nes [15, 17] , and our recent reverse transcription -polymerase chain reaction analyses demonstrated that mRNA for IL-2 and IL-4 are expressed exclusively by DETCs among the epidermal cell subpopulations. * Thus, these pathways through IL-2 and IL-4 most likely represent relevant autocrine mechanisms.
Our observation that IL-la and IL-IO failed to modulate DETC grow th was unexpected, because these two cytokines have also. bee n considered to regulate T -cell growth m other systems. IL-l prmlarily serves as a co-stimulatory factor in T-cell activation processes, by upregulating mitogen/antigen-induced IL-2 production and IL-2 receptor expression [42, 43] . Therefore, our assays, in which proliferative responses of pre-activated DETCs were measured, may not be ideal to detect possibl e effects ofIL-i. IL-I0, which is also produced by keratinocytes (8) , has been shown to modulate thymocyte/m ature T -cell proliferation (reviewed in [44] ). Again, our assays may not be suitab le fo r detecting IL-lO effects, because this cytokine appears to act primarily on antigen-presenting cells by downregul ating their function to activate T cells [45] or to affect cytokine production by a particular T-cell subset [46). Because DE~C proliferation in these assays is independent of antigen-prese ntl11g cells, It will be necessary to examine the possible roles played by IL-1 and IL-10 in assay systems in which DETC growth may rely on antige n-presenting cells.
We also sought to determine proliferative respouses of keratinocytes to epidermal cytokines. Among the cytokines tested, IL-1, IL-6, and TNFa have been reported to upregulate keratinocyte growth: 1) IL-l !l a~ been implicated as being responsible for epidermal hyperpl as ia mmflammatory skl11 disorders [47]; 2) IL-6, which also promotes the growth of human keratinocytes, is overexpressed m psonatlc skm, agall1 suggestmg its role in epidermal hyperplasia [48] ; and 3) TNFa promotes the growth of human papillomavirusmfected keratll10cytes m an autocrine mechanism [49] . In other systems, however, the growth of human keratinocytes was not affected by added . Our inab ility to detect a growthpromoting potential for these three cytokines most likely reflects the fact that each of these factors is produced endogenously (at least at mRNA levels) by the Pam 212 keratinocytes used in our study, leadll1g to the pOSSibility that their effects were already operative (Table I) [1, 2] . TI1lS assumption is supported by the unambiguous effect of IF N y, which is produced by DETCs but not by Pam 212 cells [1 6] . * In fact, this pronounced inhibition of cell growth, attributable to IFN~, has been observed in other systems [51, 52) . T hus, these observations Illustrate at least one pathway by which cytokmes produced by a resident epidermal leukocyte regulate the growth of keratinocytes .
In summary, we have demonstrated that epidermal cell subpopulations in mouse skin may affect each other through the elaboration of relevant cytokines. Three distinct mechanisms were illustrated: 1) a paracrine mechanism in w hich keratinocyte-derived cytokines (e.g., IL-7 and TNFa ) promoted the growth of DETCs; 2) an autocrine mechanism in w hich DETC-derived cytokines (e.g. , IL-2 an d IL-4) supported their own growth; and 3) a reciprocal paracrine mechanism in which a cytokine produced by a resident leukocyte modulated the growth of keratinocytes. Simo" Co., Ltd. (Tokyo) .
